Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 124

1.

Mechanisms underlying the anti-wasting effect of L-carnitine supplementation under pathologic conditions: evidence from experimental and clinical studies.

Ringseis R, Keller J, Eder K.

Eur J Nutr. 2013 Aug;52(5):1421-42. doi: 10.1007/s00394-013-0511-0. Epub 2013 Mar 19. Review.

PMID:
23508457
2.

An overview of the therapeutic effects of leucine supplementation on skeletal muscle under atrophic conditions.

Nicastro H, Artioli GG, Costa Ados S, Solis MY, da Luz CR, Blachier F, Lancha AH Jr.

Amino Acids. 2011 Feb;40(2):287-300. doi: 10.1007/s00726-010-0636-x. Epub 2010 Jun 1. Review.

PMID:
20514547
3.

Efficacy of l-carnitine administration on fatigue, nutritional status, oxidative stress, and related quality of life in 12 advanced cancer patients undergoing anticancer therapy.

Gramignano G, Lusso MR, Madeddu C, Massa E, Serpe R, Deiana L, Lamonica G, Dessì M, Spiga C, Astara G, Macciò A, Mantovani G.

Nutrition. 2006 Feb;22(2):136-45.

PMID:
16459226
4.

L-Carnitine: an adequate supplement for a multi-targeted anti-wasting therapy in cancer.

Busquets S, Serpe R, Toledo M, Betancourt A, Marmonti E, Orpí M, Pin F, Capdevila E, Madeddu C, López-Soriano FJ, Mantovani G, Macciò A, Argilés JM.

Clin Nutr. 2012 Dec;31(6):889-95. doi: 10.1016/j.clnu.2012.03.005. Epub 2012 May 19.

PMID:
22608917
5.

Effects of L-carnitine L-tartrate supplementation on muscle oxygenation responses to resistance exercise.

Spiering BA, Kraemer WJ, Hatfield DL, Vingren JL, Fragala MS, Ho JY, Thomas GA, Häkkinen K, Volek JS.

J Strength Cond Res. 2008 Jul;22(4):1130-5. doi: 10.1519/JSC.0b013e31817d48d9.

PMID:
18545197
6.

Prevention of unloading-induced atrophy by vitamin E supplementation: links between oxidative stress and soleus muscle proteolysis?

Servais S, Letexier D, Favier R, Duchamp C, Desplanches D.

Free Radic Biol Med. 2007 Mar 1;42(5):627-35. Epub 2006 Dec 15.

7.

Regulation of skeletal muscle plasticity by glycogen synthase kinase-3β: a potential target for the treatment of muscle wasting.

Verhees KJ, Pansters NA, Schols AM, Langen RC.

Curr Pharm Des. 2013;19(18):3276-98. Review.

PMID:
23151136
8.

Can the use of creatine supplementation attenuate muscle loss in cachexia and wasting?

Sakkas GK, Schambelan M, Mulligan K.

Curr Opin Clin Nutr Metab Care. 2009 Nov;12(6):623-7. doi: 10.1097/MCO.0b013e328331de63. Review.

9.

L-carnitine supplementation in dialysis: treatment in quest of disease.

Wasserstein AG.

Semin Dial. 2013 Jan-Feb;26(1):11-5. doi: 10.1111/sdi.12041. Epub 2012 Nov 22.

PMID:
23173999
10.

β2-Adrenergic agonists and the treatment of skeletal muscle wasting disorders.

Joassard OR, Durieux AC, Freyssenet DG.

Int J Biochem Cell Biol. 2013 Oct;45(10):2309-21. doi: 10.1016/j.biocel.2013.06.025. Epub 2013 Jul 8. Review.

PMID:
23845739
11.

Myostatin inhibitors as therapies for muscle wasting associated with cancer and other disorders.

Smith RC, Lin BK.

Curr Opin Support Palliat Care. 2013 Dec;7(4):352-60. doi: 10.1097/SPC.0000000000000013. Review.

12.

Leucine as a treatment for muscle wasting: a critical review.

Ham DJ, Caldow MK, Lynch GS, Koopman R.

Clin Nutr. 2014 Dec;33(6):937-45. doi: 10.1016/j.clnu.2014.09.016. Review.

PMID:
25444557
13.

Supplementation with l-carnitine downregulates genes of the ubiquitin proteasome system in the skeletal muscle and liver of piglets.

Keller J, Ringseis R, Koc A, Lukas I, Kluge H, Eder K.

Animal. 2012 Jan;6(1):70-8. doi: 10.1017/S1751731111001327.

PMID:
22436156
14.

The role of beta-adrenoceptor signaling in skeletal muscle: therapeutic implications for muscle wasting disorders.

Koopman R, Ryall JG, Church JE, Lynch GS.

Curr Opin Clin Nutr Metab Care. 2009 Nov;12(6):601-6. doi: 10.1097/MCO.0b013e3283318a25. Review.

PMID:
19741516
15.

Mitochondrial plasticity in cancer-related muscle wasting: potential approaches for its management.

Vitorino R, Moreira-Gonçalves D, Ferreira R.

Curr Opin Clin Nutr Metab Care. 2015 May;18(3):226-33. doi: 10.1097/MCO.0000000000000161. Review.

PMID:
25783794
16.

Targeting the myostatin signaling pathway to treat muscle wasting diseases.

Han HQ, Mitch WE.

Curr Opin Support Palliat Care. 2011 Dec;5(4):334-41. doi: 10.1097/SPC.0b013e32834bddf9. Review.

17.

Factors contributing to muscle wasting and dysfunction in COPD patients.

Wüst RC, Degens H.

Int J Chron Obstruct Pulmon Dis. 2007;2(3):289-300. Review.

18.

Effects of L-carnitine supplementation on muscular symptoms in hemodialyzed patients.

Sakurauchi Y, Matsumoto Y, Shinzato T, Takai I, Nakamura Y, Sato M, Nakai S, Miwa M, Morita H, Miwa T, Amano I, Maeda K.

Am J Kidney Dis. 1998 Aug;32(2):258-64.

PMID:
9708610
19.

Grape seed extract prevents skeletal muscle wasting in interleukin 10 knockout mice.

Wang B, Yang G, Liang X, Zhu M, Du M.

BMC Complement Altern Med. 2014 May 20;14:162. doi: 10.1186/1472-6882-14-162.

20.

Selective androgen receptor modulators for the prevention and treatment of muscle wasting associated with cancer.

Dalton JT, Taylor RP, Mohler ML, Steiner MS.

Curr Opin Support Palliat Care. 2013 Dec;7(4):345-51. doi: 10.1097/SPC.0000000000000015. Review.

PMID:
24189892
Items per page

Supplemental Content

Write to the Help Desk